Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

CRISPR/Cas9 Genome Editing

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...

CRISPR

CRISPR

CRISPR and crRNAs

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...

Eukaryotic Transcription Activators

Eukaryotic Transcription Activators

Transcription activators are proteins that promote the transcription of genes from DNA to RNA. In most cases, these proteins contain two separate domains ‒ a domain that binds to DNA and a domain for activating transcription; however, in some cases, a single domain is responsible for both binding and activation of transcription, as seen in the glucocorticoid receptor and MyoD.
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...

Homologous Recombination

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Coordinated changes in microbiota features, short-chain fatty acids, and peripheral clocks accompany fructo-oligosaccharide-associated metabolic improvement.

Food & function·2026

Same author

Genome-Wide Analysis and Expression Profiles of <i>AhLOG</i> Gene Family in Peanut (<i>Arachis hypogaea</i> L.).

International journal of molecular sciences·2026

Same author

A Synthetic Data-Augmented Deep Learning Framework for Robust Segmentation and Quantification of the Carotid Artery in Ultrasound Images.

Ultrasound in medicine & biology·2026

Same author

Genome-wide association analysis identifies novel genetic loci and candidate genes associated with seed dormancy in cultivated peanut.

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2026

Same author

Development and applications of A-genome chromosome-specific oligo pools for peanut genomic relationships revealing and single-chromosome microdissection.

The Plant journal : for cell and molecular biology·2026

Same author

A bacteriophage-encoded protein gp119 suppresses deoxyinosine repair to protect hypermutated viral genome.

iScience·2026

Same journal

A Framework for the In Vivo Production of Extensively Engineered Thiopeptides.

ACS synthetic biology·2026

Same journal

A Highly Stringent Split Intein-Mediated DHFR Selectable Marker Enables Efficient Development of High-Producing CHO Cells for Therapeutic Proteins.

ACS synthetic biology·2026

Same journal

Breaking the Stability-Activity-Selectivity Trilemma in Unspecific Peroxygenase through Computation-Based Cross-Regional Combinatorial Mutagenesis.

ACS synthetic biology·2026

Same journal

Sequential Plasmid Curing and Genome Editing in <i>Escherichia coli</i> Nissle 1917.

ACS synthetic biology·2026

Same journal

An Explainable Deep Learning Framework Integrating DNA Sequence and Transcription Initiation Signals for Gene Expression Prediction.

ACS synthetic biology·2026

Same journal

A Multitask Prediction Framework for CircRNAs, Drugs, and Diseases Based on Multi-View Information Integration and Graph Contrastive Learning.

ACS synthetic biology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Apr 2, 2026

Gene Digital Circuits Based on CRISPR-Cas Systems and Anti-CRISPR Proteins

Gene Digital Circuits Based on CRISPR-Cas Systems and Anti-CRISPR Proteins

Published on: October 18, 2022

Engineering Translational Activators with CRISPR-Cas System.

Pei Du¹, Chensi Miao^1,2, Qiuli Lou³

¹CAS Key Laboratory of Microbial Physiological and Metabolic Engineering, Institute of Microbiology, Chinese Academy of Sciences ; Beijing, 100101, China.

ACS Synthetic Biology

|September 29, 2015

Summary

This summary is machine-generated.

Scientists engineered novel translational activators using an RNA endoribonuclease (Csy4) and RNA modules. This system efficiently controls gene expression at the translation level, offering enhanced genetic engineering capabilities.

Keywords:

CRISPR endoribonuclease Csy4 RBS calculator modularization orthogonal parts translational activator

More Related Videos

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing

Published on: May 5, 2023

CRISPR Epigenome Editing in Human Cells using Plasmid DNA Transfection and mRNA Nucleofection Delivery

CRISPR Epigenome Editing in Human Cells using Plasmid DNA Transfection and mRNA Nucleofection Delivery

Published on: May 30, 2025

Related Experiment Videos

Last Updated: Apr 2, 2026

Gene Digital Circuits Based on CRISPR-Cas Systems and Anti-CRISPR Proteins

Gene Digital Circuits Based on CRISPR-Cas Systems and Anti-CRISPR Proteins

Published on: October 18, 2022

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing

Published on: May 5, 2023

CRISPR Epigenome Editing in Human Cells using Plasmid DNA Transfection and mRNA Nucleofection Delivery

CRISPR Epigenome Editing in Human Cells using Plasmid DNA Transfection and mRNA Nucleofection Delivery

Published on: May 30, 2025

Area of Science:

Synthetic Biology
Molecular Biology
Genetic Engineering

Background:

RNA components are essential for genetic engineering applications.
Controlling gene expression at the translation level is crucial for synthetic biology.
Existing translational activators, like small RNAs, have limitations in unfolding RNA duplexes.

Purpose of the Study:

To design and characterize a novel RNA endoribonuclease-based translational activator system.
To demonstrate the modularity and tunability of the developed translational activators.
To assess the feasibility of replacing components with orthogonal homologues for broader applications.

Main Methods:

Utilized the Csy4 endoribonuclease and specific RNA modules to create a translational activation system.
Engineered cis-repressive RNA (crRNA) and ribosome binding site (RBS) modules for tunable translation initiation.
Demonstrated the release of a crRNA from a masked RBS upon Csy4-mediated cleavage.
Showcased the exchangeability of the Csy4-recognition site module with orthogonal endoribonuclease-recognition site homologues.

Main Results:

Developed a translational activator system based on Csy4 endoribonuclease and exchangeable RNA modules.
Achieved efficient unfolding of RBS-crRNA duplexes, enabling translation initiation.
Demonstrated successful modulation of translational activity by engineering the crRNA-RBS duplex.
Confirmed the interchangeability of the Csy4 module with orthogonal systems.

Conclusions:

The novel endoribonuclease-based translational activators offer high performance and modularity.
This system provides a feasible platform for programming gene expression at the translation level.
The design enhances control over translation initiation in genetic engineering applications.